Clinical Trial Update: Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating montelukast for preventing transaminase elevation in adult dengue patients; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Dengue, Montelukast | Phase 2, Phase 3 | Status: RECRUITING